140 related articles for article (PubMed ID: 16815295)
1. p73 and MDM2 confer the resistance of epidermoid carcinoma to cisplatin by blocking p53.
Hayashi S; Ozaki T; Yoshida K; Hosoda M; Todo S; Akiyama S; Nakagawara A
Biochem Biophys Res Commun; 2006 Aug; 347(1):60-6. PubMed ID: 16815295
[TBL] [Abstract][Full Text] [Related]
2. p73 expression modulates p63 and Mdm2 protein presence in complex with p53 family-specific DNA target sequence in squamous cell carcinogenesis.
Johnson J; Lagowski J; Lawson S; Liu Y; Kulesz-Martin M
Oncogene; 2008 Apr; 27(19):2780-7. PubMed ID: 18026135
[TBL] [Abstract][Full Text] [Related]
3. Subcellular distribution of p53 and p73 are differentially regulated by MDM2.
Gu J; Nie L; Kawai H; Yuan ZM
Cancer Res; 2001 Sep; 61(18):6703-7. PubMed ID: 11559539
[TBL] [Abstract][Full Text] [Related]
4. Functional interplay between MDM2, p63/p73 and mutant p53.
Stindt MH; Muller PA; Ludwig RL; Kehrloesser S; Dötsch V; Vousden KH
Oncogene; 2015 Aug; 34(33):4300-10. PubMed ID: 25417702
[TBL] [Abstract][Full Text] [Related]
5. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.
Mujoo K; Watanabe M; Nakamura J; Khokhar AR; Siddik ZH
J Cancer Res Clin Oncol; 2003 Dec; 129(12):709-18. PubMed ID: 14513366
[TBL] [Abstract][Full Text] [Related]
6. A possible role of p73 on the modulation of p53 level through MDM2.
Wang XQ; Ongkeko WM; Lau AW; Leung KM; Poon RY
Cancer Res; 2001 Feb; 61(4):1598-603. PubMed ID: 11245471
[TBL] [Abstract][Full Text] [Related]
7. MDM2 and MDMX bind and stabilize the p53-related protein p73.
Ongkeko WM; Wang XQ; Siu WY; Lau AW; Yamashita K; Harris AL; Cox LS; Poon RY
Curr Biol; 1999 Jul 29-Aug 12; 9(15):829-32. PubMed ID: 10469568
[TBL] [Abstract][Full Text] [Related]
8. MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro.
Wang J; Zheng T; Chen X; Song X; Meng X; Bhatta N; Pan S; Jiang H; Liu L
J Gastroenterol Hepatol; 2011 Feb; 26(2):371-7. PubMed ID: 21261729
[TBL] [Abstract][Full Text] [Related]
9. Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1.
Ray RM; Bhattacharya S; Johnson LR
Apoptosis; 2011 Jan; 16(1):35-44. PubMed ID: 20812030
[TBL] [Abstract][Full Text] [Related]
10. c-Jun regulates the stability and activity of the p53 homologue, p73.
Toh WH; Siddique MM; Boominathan L; Lin KW; Sabapathy K
J Biol Chem; 2004 Oct; 279(43):44713-22. PubMed ID: 15302867
[TBL] [Abstract][Full Text] [Related]
11. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
[TBL] [Abstract][Full Text] [Related]
12. Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73.
Zdzalik M; Pustelny K; Kedracka-Krok S; Huben K; Pecak A; Wladyka B; Jankowski S; Dubin A; Potempa J; Dubin G
Cell Cycle; 2010 Nov; 9(22):4584-91. PubMed ID: 21088494
[TBL] [Abstract][Full Text] [Related]
13. p73-dependent induction of 14-3-3sigma increases the chemo-sensitivity of drug-resistant human breast cancers.
Sang M; Li Y; Ozaki T; Ono S; Ando K; Yamamoto H; Koda T; Geng C; Nakagawara A
Biochem Biophys Res Commun; 2006 Aug; 347(1):327-33. PubMed ID: 16814250
[TBL] [Abstract][Full Text] [Related]
14. Relief of p53-mediated telomerase suppression by p73.
Toh WH; Kyo S; Sabapathy K
J Biol Chem; 2005 Apr; 280(17):17329-38. PubMed ID: 15734740
[TBL] [Abstract][Full Text] [Related]
15. Identification of a sequence element from p53 that signals for Mdm2-targeted degradation.
Gu J; Chen D; Rosenblum J; Rubin RM; Yuan ZM
Mol Cell Biol; 2000 Feb; 20(4):1243-53. PubMed ID: 10648610
[TBL] [Abstract][Full Text] [Related]
16. Cooperation between p53 and p73 in cisplatin-induced apoptosis in ovarian carcinoma cells.
Righetti SC; Perego P; Carenini N; Zunino F
Cancer Lett; 2008 May; 263(1):140-4. PubMed ID: 18261847
[TBL] [Abstract][Full Text] [Related]
17. MDM2 promotes the proteasomal degradation of p73 through the interaction with Itch in HeLa cells.
Kubo N; Okoshi R; Nakashima K; Shimozato O; Nakagawara A; Ozaki T
Biochem Biophys Res Commun; 2010 Dec; 403(3-4):405-11. PubMed ID: 21093410
[TBL] [Abstract][Full Text] [Related]
18. HDM2 impairs Noxa transcription and affects apoptotic cell death in a p53/p73-dependent manner in neuroblastoma.
Shi Y; Takenobu H; Kurata K; Yamaguchi Y; Yanagisawa R; Ohira M; Koike K; Nakagawara A; Jiang LL; Kamijo T
Eur J Cancer; 2010 Aug; 46(12):2324-34. PubMed ID: 20591651
[TBL] [Abstract][Full Text] [Related]
19. Modulation of p53 and p73 levels by cyclin G: implication of a negative feedback regulation.
Ohtsuka T; Ryu H; Minamishima YA; Ryo A; Lee SW
Oncogene; 2003 Mar; 22(11):1678-87. PubMed ID: 12642871
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of p73 and p53 regulation and effector functions.
Fang L; Lee SW; Aaronson SA
J Cell Biol; 1999 Nov; 147(4):823-30. PubMed ID: 10562283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
